Abstract

 The term mental disease is not restricted to mean insanity and allied conditions of mental derangement but also includes, to a certain extent, the emotional disorders. When emotional factors cross the state of normalcy, one gets deranged to show the syndromes of mental disorder, very often. These pathologies affect all categories of person, race, sex and age. Many synthetic psychoactive molecules such as antiepileptic, antidepressants, anxiolytics are used in modern medicine to treat these pathologies. But allopathic medicine is not found very effective. Further, cost, dependency on diagnostic tools, increasing adverse effects and symptomatic rather than curative approach of allopathic medicine made the world population seeking an alternative medical system. Currently, the world is looking towards traditional medicines, including Unani pathy for a reliable cure for psychiatric disorders. Little research has approached the specific case of plants used to treat nervous system disorders. It is necessary to report psychic disorders treated by medicinal plants in Unani Medicine. It is high time to look back to the Unani system of medicine wherein a number of plants and mineral origin drugs have been described for specific uses for a range of mental disorders. An attempt has been made in this paper to highlight the beneficial Unani plant origin drugs in psychiatric problems. These plants have been reported for their potential in treating many neuropsychiatric problems. Some research studies conducted on the scientific parameters on the plant drugs will also be provided to show the potential of these drugs which may help in development of new intervention or a substitute for conventional drug, or that can be used as an adjuvant.

Keywords: Psychiatric Disorders; Unani Medicine; Adjuvant; Amraz-I Nafsaniya

References

1. Mental health (2018).
2. Roy RN., et al. “Textbook of Preventive and Social Medicine”. 4^th Jaypee Brothers Medical Publishers (P) Ltd, New Delhi (2013): 642-649.
3. Taylor DJ., et al. “Insomnia as a health risk factor”. Behavioral Sleep Medicine 4 (2003): 227-247.
4. World Health Organization (WHO). “Mental Health Gap Action Programme: Scaling up Care for Mental, Neurological, and Substance Use Disorders”. WHO: Geneva, Switzerland (2008).
5. Ibn Sina. Al-Qanoon fi al-Tibb, Volume III part I (A), Jamia Hamdard, New Delhi (1989): 8, 19, 21-31, 83-85.
6. Majusi MA. Kamil al-Sana fi al-Tibb, Volume I (A), Central Council for Research in Unani Medicine, New Delhi 216 (2005): 93-97.
7. Ibn Rushd. Kitab al-Kulliyat (A), Central Council for Research in Unani Medicine, New Delhi (1984): 40.
8. Al-Razi ABZ. Al-Hawi fi al-Tibb, Volume I (A), Daira Ma’arifa Usmania, Hyderabad (1955): 96-97.
9. Khan MA. Ikseer-i Azam, Volume I (P), Matba Nami Munshi Naval Kishor Lucknow. NM 185.
10. Baghdadi I H. Kitab al-Mukhtarat, Volume III (A), Daira Maarifa Usmaniya, Hyderabad (1363): 30.
11. Al-Qamri N. Ghina Muna, CCRUM, New Delhi (2008): 15-18.
12. Jurjani I. Zakhira Khwarizm Shahi, Volume 10, (Urdu translation), Matba Munshi Naval Kishore, Kanpur (1889): 7-9.
13. Majusi MA. Kamil al-Sana fi al-Tibb, Central Council for Research in Unani Medicine, New Delhi 18 (2005): 262-267.
14. Ibn Sina. Al-Qanoon fi al-Tibb, Jamia Hamdard, New Delhi (1987): 52.
15. Baghdadi I H. Kitab al-Mukhtarat, Daira Ma’arifa Usmania, Hyderabad (1364): 139.
16. Ibn Baitar. Al-Jami Li Mufradat al- Advia wa al-Aghziya, Volume I, Central Council for Research in Unani Medicine, New Delhi 73 (1985): 94-96.
17. Shirazi MMH., Makhzan al-Advia, Matba Ahmadi, Shahdara, Delhi 1278 AH: 89-90, 109, 127, 562-563.
18. Nabi G. Makhzan al-Mufradat wa Murakkabat, Central Council for Research in Unani Medicine, New Delhi (2007): 34, 41, 64, 149, 204, 247.
19. Ghani NM. Khazain al-Advia, Idara Kitab al-Shifa, Delhi. NM: 366, 839, 1116, 1135.
20. Gupta M., et al. “Studies on brain biogenic amines in methanolic extract of Cuscuta reflexa Roxb and Linn seed treated mice”. Acta Poloniae Pharmaceutica-Drug Research3 (2003): 207-210.
21. Thomas S., et al. “Evaluation of anxioltic effect of whole plant of “Cuscuta reflexa”. World Journal of Pharmacy and Pharmaceutical Sciences8 (2015): 1245-1253.
22. Safiuddin SS. Unani Mufradah Advia, Taraqqi Urdu Bureau, Delhi (1993): 33, 74-75.
23. Attari M., et al. “Effect of Withania somnifera Dunal Root Extract on Behavioral Despair Model in Mice: A Possible Role for Nitric Oxide”. Acta Medica Iranica 3 (2016): 165-172.
24. Khare CP. “Indian Medicinal Plants-An Illustrated Dictionary”. 1^st New York: Springer (2007): 652-665, 717-718.
25. Ninadh Malrina D'Costa., et al. “Antidepressant Activity of Ethanolic Extract of Whole Plant of Ashwagandha (Withania somnifera), a Popular Medicinal Plant of Indian Subcontinent”. Asian Journal of Biological and Life Sciences 3 (2012): 247-251.
26. Antaki D. Tazkira Ulil al-Baab, Volume I (A), Printed by Central Council for Research in Unani Medicine, New Delhi (2008): 114, 122, 137-138, 531, 642.
27. Said HM. “Hamdard Pharmacopoeia of eastern medicine”. Sri Satguru Publications (1977): 985-988.
28. Hakeem MA. “Bustan al- Mufradat, Musawwar Edition”. Idara Kitabus-Shifa New Delhi (2002): 92.
29. Mannan A., et al. “Pharmacodynamic studies on Polypodium vulgare L”. Indian Journal of Experimental Biology 27 (1989): 556-560.
30. Al-Razi ABZ. Al-Hawi fi al-Tibb, Volume 20, (A), Daira Ma’arifa Usmania Hyderabad (1965): 106.
31. Kabiruddin M. Makhzan al-Mufradat, Maroof ba Khawas al-Advia, Aijaz Publishing house, Urdu bazar Lahore. NM: 55, 109, 112, 127-128, 359-360, 490.
32. Dhingra D., et al. “Possible involvement of monoaminergic neurotransmission in antidepressant like activity of Emblica officinalis fruits in mice”. CNS Neuroscience and Therapeutics 18 (2012): 419 425.
33. Khan MA. Muheet-i Azam, Volume I, (P), Matba Nizami, Kanpur (1303): 244-245.
34. Lubhaya RH. Bayan al-Advia, Volume I, Goswami Kutub khana, Delhi. NM: 122.
35. Hakeem A. Mufradat-i Azeezi (Urdu), Matbua Sahitya Mandir Press Ltd. Lucknow (1948): 83, 86.
36. Bora KS and Dubey A. “Evaluation of anti-anxiety activity of M parviflora (Benth.) in rats”. The Thai Journal of Pharmaceutical Sciences3 (2015): 70-75.
37. Khan MS. Taleef Shareefi, Akmal al-Mataba, Delhi (1847): 36.
38. Achliya G., et al. “Effect of Brahmi Ghrita, a polyherbal formulation on learning and memory paradigms in experimental animals”. Indian Journal of Pharmacology 3 (2008): 159-162.
39. Nathan PJ., et al. “The acute effect of an extract of Bacopa monniera (Brahmi) on cognitive functions in healthy normal subjects”. Human Psychopharmacology Clinical and Experimental 16 (2001): 345-351.
40. Biswas SK., et al. “Evaluation of antinociceptive and antioxidant activities of whole plant extract of Bacopa monniera”. Research Journal of Medicinal Plant 8 (2012): 607-614.
41. “Bacopa monnieri – a preliminary study evaluating its anti-stress activity in Swiss albino mice”. Research Journal of Pharmaceutical, Biological and Chemical Sciences 2.4 (2011):786-794.
42. Kathryn E Wellen and Gokhan S Hotamisligil. “Inflammation, stress, and diabetes”. Journal of Clinical Investigation 5 (2005): 1111-1119.
43. Razi ABZ. Al-Hawi fi al-Tibb, Volume 21, part II (A), Daira Ma’arifa Usmania, Hyderabad (1968): 626-628, 637.
44. Al-Attar Z A. Ikhtiyaraat Badeei, Matbanami Munshi Naval Kishor, Kanpur (1888): 45.
45. CL Lin CS. “Development of antioxidant activity and pattern recognition of Terminalia chebula Retzius extracts and its fermented products”. Hung Kuang Journal 61 (2010): 115-129.
46. Kumar B., et al. “Anticonvulsant activity of ethanolic extract of fruits of Terminalia chebula on experimental animals”. International Journal of Drug development and Research4 (2010): 764-768.
47. Chandra SR., et al. “Antidepressant activity of aqueous extract of Terminalia chebula in rats”. International Journal of Pharmacy and Pharmaceutical Sciences4 (2012): 449-451.
48. Onasanwo SA., et al. “Antidepressant and Anxiolytic Potentials of Chebulinic Acid in Laboratory Rodent”. Annals of Depression and Anxiety 7 (2014): 5.
49. Chialin C and CheSan L. “Phytochemical composition, Antioxidant activity and Neuroprotective effect of T chebula Extracts”. Evidence -Based Complementary and Alternative Medicine (2012): 1-7.
50. Fatemeh G., et al. “Protective Effects of Borago officinalis Extract on Amyloid β-Peptide(25–35)-Induced Memory Impairment in Male Rats: A Behavioral Study”. BioMed Research International (2014): 8.
51. Cathy JF., et al. “Effectiveness of treatments for depression in older people”. Medical Journal of Australia 182 (2005): 627-632.
52. Khan MA. Muheet-i Azam, Volume-III, (P), Matba Nizami Kanpur (1313): 34-35.
53. S Zhou Z., et al. “Phenolic glycosides from the rhizomes of Cyperus rotundus and their antidepressant activity”. Journal of Korean Society for Applied Biological Chemistry5 (2015): 685-691.
54. Sutlangka C and Wattanathorn J. “Neuroprotective and cognitive-enhancing effects of the combined extract of Cyperus rotundus and Zingiber officinale”. BMC Complementary and Alternative Medicine (2017): 135.
55. Rizwan M and Khan AA. “Assessment of efficacy of Sankhahuli (Convolvulus pluricaulis Chois.) and gokhru (Tribulus terrestris) in the management of hypertension”. Indian Journal of Traditional Knowledge (IJTK) 13.2 (2014): 313-318.
56. Shamsi Y., et al. “A Clinical study on the management of anxiety neurosis with sankhaholi”. Indian Journal of Traditional Knowledge4 (2007): 668-677.
57. Gupta P., et al. “Anti-stress Constituents of Evolvulus alsinoides, An Ayurvedic Crude”. Chemical and Pharmaceutical Bulletin 55 (2007): 771.
58. Dhingra D and Goyal P K. “Inhibition of MAO and GABA: Probable mechanisms for antidepressant-like activity of jatamansi DC in mice”. Indian Journal of Experimental Biology 46 (2008): 212-218.
59. Ibn Baitar. Al-Jami li Mufradat al-Adviya wa al-Aghziya, Volume III, Central Council for Research in Unani Medicine. New Delhi (1999): 189-190.
60. Dolati K., et al. “Antidepressant-like effect of aqueous extract from Rosa damascena in mice”. Avicenna Journal of Phytomedicine2 (2011): 91-97.
61. Homayoun M., et al. “Anticonvulsant and neuroprotective effects of Rosa damascena hydro-alcoholic extract on rat hippocampus”. Avicenna Journal of Phytomedicine3 (2015): 260-270.
62. Kheirabadi M., et al. “Evaluation of the Anti convulsant activities of Rosa damascena on the PTZ Induced Seizures in Wistar Rats”. Journal of Biological Sciences2 (2008): 426-430.
63. Kwon E‐K., et al. “Flavonoids from the buds of Rosa damascena inhibit the activity of 3‐hydroxy‐3‐methylglutaryl‐coenzyme a reductase and angiotensin I‐converting enzyme”. Journal of Agricultural and Food Chemistry 58 (2009): 882-886.

Citation

Citation: Azma Waseem., et al. “Medicinal Plants Used for Treatment of Psychiatric Disorders in Unani Medicine".Acta Scientific Neurology 3.6 (2020): 11-17.

Copyright

Copyright: © 2020 Azma Waseem., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.